For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.
In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
The cyberattack at CareCloud resulted in one of the largest reported data breaches in the U.S. healthcare industry this year.
Full body MRIs may detect early, symptomless cancer tumors or other serious issues, but may also return benign findings that cause unecessary anxiety and intervention.
Informing consumers and promoting innovative US manufacturing is a surer and safer path to reducing America’s reliance on imported drugs of uncertain quality
Electronic health record giant Epic Systems is working with medical care providers and two of the nation’s largest health insurers to speed prior authorization reviews.
Postpartum depression affects 1 in 7 women but 60% never get help. What to recognize, how to get treatment, and why preparedness matters—explained.
Centene, one of the nation’s largest providers of Obamacare, said chief financial officer Drew Asher plans to step down as chief financial officer in December.
A physician explains the FDA’s proposed GRAS rule, what it means for food safety and whether mandatory notification will actually change what’s in your food.
It would be medical malpractice to continue—and indeed expand—a particularly bad Biden-era healthcare initiative.